BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9792145)

  • 21. The effect of amifostine on the in vitro cytotoxicity of chemotherapeutic agents in three epithelial ovarian carcinoma cell lines.
    Ng TY; Ngan HY; Cheng DK; Wong LC
    Gynecol Oncol; 1999 Nov; 75(2):194-7. PubMed ID: 10525371
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhancement of radiation effects by combined docetaxel and carboplatin treatment in vitro.
    Amorino GP; Hamilton VM; Choy H
    Radiat Oncol Investig; 1999; 7(6):343-52. PubMed ID: 10644057
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of a vitamin D3 analog, EB1089, on hematopoietic stem cells from normal and myeloid leukemic blasts.
    Lee YY; Kim ES; Seol JG; Kim BK; Binderup L; Elstner E; Park DJ; Koeffler HP
    Leukemia; 1996 Nov; 10(11):1751-7. PubMed ID: 8892678
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protective effect of amifostine against toxicity of paclitaxel and carboplatin in non-small cell lung cancer: a single center randomized study.
    Kanat O; Evrensel T; Baran I; Coskun H; Zarifoglu M; Turan OF; Kurt E; Demiray M; Gonullu G; Manavoglu O
    Med Oncol; 2003; 20(3):237-45. PubMed ID: 14514973
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A pilot study of addition of amifostine to melphalan, carboplatin, etoposide, and cyclophosphamide with autologous hematopoietic stem cell transplantation in pediatric solid tumors-A pediatric blood and marrow transplant consortium study.
    Ozkaynak MF; Sahdev I; Gross TG; Levine JE; Cheerva AC; Richards MK; Rozans MK; Shaw PJ; Kadota RP
    J Pediatr Hematol Oncol; 2008 Mar; 30(3):204-9. PubMed ID: 18376282
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro toxicity of ET-743 and aplidine, two marine-derived antineoplastics, on human bone marrow haematopoietic progenitors. comparison with the clinical results.
    Albella B; Faircloth G; López-Lázaro L; Guzmán C; Jimeno J; Bueren JA
    Eur J Cancer; 2002 Jul; 38(10):1395-404. PubMed ID: 12091072
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The evaluation of amifostine for mucosal protection in patients with advanced loco-regional squamous cell carcinomas of the head and neck (SCCHN) treated with concurrent weekly carboplatin, paclitaxel, and daily radiotherapy (RT).
    Suntharalingam M; Jaboin J; Taylor R; Wolf J; Banglore M; Van Echo D; Ord R
    Semin Oncol; 2004 Dec; 31(6 Suppl 18):2-7. PubMed ID: 15726515
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of amifostine on neuroblastoma during high dose chemotherapy: in vivo and in vitro investigations.
    Renner S; Krümpelmann S; Bruchelt G; Wiesinger H; Niethammer D; Klingebiel T
    Anticancer Res; 2000; 20(6B):4531-8. PubMed ID: 11205300
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neurophysiological study of peripheral neuropathy after high-dose Paclitaxel: lack of neuroprotective effect of amifostine.
    Openshaw H; Beamon K; Synold TW; Longmate J; Slatkin NE; Doroshow JH; Forman S; Margolin K; Morgan R; Shibata S; Somlo G
    Clin Cancer Res; 2004 Jan; 10(2):461-7. PubMed ID: 14760066
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The influence of amifostine used alone or in combination with 2-chlorodeoxyadenosine on normal and chronic myelogenous leukemia granulocyte-macrophage progenitor cells in vitro.
    Korycka A; Robak T
    Arch Immunol Ther Exp (Warsz); 2000; 48(4):293-9. PubMed ID: 11059647
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of caspase 3 and modulation of some apoptotic genes in human acute promyelocytic leukemia HL-60 cells by carboplatin with amifostine.
    Mirowski M; Rózalski M; Krajewska U; Balcerczak E; Młynarski W; Wierzbicki R
    Pol J Pharmacol; 2003; 55(2):227-34. PubMed ID: 12926551
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The potential of amifostine: from cytoprotectant to therapeutic agent.
    Santini V; Giles FJ
    Haematologica; 1999 Nov; 84(11):1035-42. PubMed ID: 10553165
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carboplatin combined with amifostine, a bone marrow protectant, in the treatment of non-small-cell lung cancer: a randomised phase II study.
    Betticher DC; Anderson H; Ranson M; Meely K; Oster W; Thatcher N
    Br J Cancer; 1995 Dec; 72(6):1551-5. PubMed ID: 8519676
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro cytoprotective activity of squalene on a bone marrow versus neuroblastoma model of cisplatin-induced toxicity. implications in cancer chemotherapy.
    Das B; Yeger H; Baruchel H; Freedman MH; Koren G; Baruchel S
    Eur J Cancer; 2003 Nov; 39(17):2556-65. PubMed ID: 14602142
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carboplatin and paclitaxel in non-small cell lung cancer: the role of amifostine.
    Selvaggi G; Belani CP
    Semin Oncol; 1999 Apr; 26(2 Suppl 7):51-60. PubMed ID: 10348261
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antitumor effect and potentiation of cytotoxic drugs activity in human cancer cells by ZD-1839 (Iressa), an epidermal growth factor receptor-selective tyrosine kinase inhibitor.
    Ciardiello F; Caputo R; Bianco R; Damiano V; Pomatico G; De Placido S; Bianco AR; Tortora G
    Clin Cancer Res; 2000 May; 6(5):2053-63. PubMed ID: 10815932
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Docetaxel in combination with platinums in patients with advanced non-small-cell lung cancer.
    Belani CP
    Oncology (Williston Park); 1997 Aug; 11(8 Suppl 8):42-5. PubMed ID: 9364542
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amifostine does not protect malignant lymphoma cell lines from the cytotoxic effects of various chemotherapeutics in vitro.
    Kuittinen O; Ruokolainen H; Turpeenniemi-Hujanen T
    Leuk Lymphoma; 2001 Jul; 42(3):507-10. PubMed ID: 11699416
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early tandem high-dose ifosfamide, carboplatin, etoposide therapy with stem cell rescue for small-cell lung cancer: brief report on the results of a phase-I/II trial.
    Oelmann E; Thomas M; Serve H; Kienast J; Zühlsdorf M; Mohr M; Klinke F; Dölken G; Macha H; Schmidt EW; Berdel WE
    Oncology; 2002; 63(3):248-53. PubMed ID: 12381904
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Approaches to managing carboplatin-induced thrombocytopenia: focus on the role of amifostine.
    Budd GT; Ganapathi R; Wood L; Snyder J; McLain D; Bukowski RM
    Semin Oncol; 1999 Apr; 26(2 Suppl 7):41-50. PubMed ID: 10348260
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.